To evaluate the clinical relevance of TRPV2 expression in lung cancer, gene expression analysis was performed using The Cancer Genome Atlas (TCGA) dataset, where it was found that patients with lung adenocarcinoma had higher expression of TRPV2 compared to patients with squamous cell carcinoma (Figure 6A). This evidence concerns the gene TRPV2 and lung carcinoma.